Looking for a BREAKOUT Nasdaq Stock for Tuesday? $VCEL
Manic Stock Alerts We Are Looking at VCEL Verical Corp. Tomorrow and Looking at Her as a Swing Trade Not Just a Hit & Run Trading Idea. This Baby Has Climbed Above her Weekly 50ma Resistance and This Chart Has Huge Upside Potential!
This Chart Has Been Waiting for a Catalyst and Think We Saw This with Last Nights Earnings Press Release! Vericel ReportsTotal Revenues of $14.7 Million Reported for the Fourth Quarter
Could VCEL Be Setting Up to Head Towards 2012 Highs of Over 69.00 a Share??
Website:http://www.vcel.com/ Developing Patient Specific Expanded Cellular Therapies
Vericel Corporation (formerly Aastrom Biosciences) is the leader in developing patient-specific expanded cellular therapies for use in the treatment of patients with severe diseases and conditions. The company markets two cell therapy products in the United States, Carticel® (autologous cultured chondrocytes), an autologous chondrocyte implant for the treatment of cartilage defects in the knee, and Epicel® (cultured epidermal autografts), a permanent skin replacement for the treatment of patients with deep dermal or full thickness burns comprising greater than or equal to 30% of total body surface area. Vericel is also developing MACI, a third-generation autologous chondrocyte implant for the treatment of cartilage defects in the knee, and ixmyelocel-T, a patient specific multicellular therapy for the treatment of advanced heart failure due to ischemic dilated cardiomyopathy (DCM).